SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation
Your view on ICU
Overview
What the company does, where it operates, and who runs it.
About SeaStar Medical Holding Corporation
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Eric Schlorff
- Headquarters
- 3513 Brighton Boulevard, Denver, CO, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Eric Schlorff
- Headquarters
- 3513 Brighton Boulevard, Denver, CO, US
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients.
The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for SeaStar Medical Holding Corporation, and the rating behind it. ICU last traded at $3.03; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for SeaStar Medical Holding Corporation. Starting points for SeaStar Medical Holding Corporation: EPS -$3.34, beta -1.03 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for SeaStar Medical Holding Corporation. SeaStar Medical Holding Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for SeaStar Medical Holding Corporation. Trailing twelve-month EPS for SeaStar Medical Holding Corporation stands at -$3.34. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for SeaStar Medical Holding Corporation. SeaStar Medical Holding Corporation has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
SeaStar Medical Holding Corporation valued side by side against its closest peers. SeaStar Medical Holding Corporation is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold SeaStar Medical Holding Corporation, and how their positions are changing. At a $8.6M market value, institutional positions materially move SeaStar Medical Holding Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by SeaStar Medical Holding Corporation executives and directors. Shares of SeaStar Medical Holding Corporation have traded between $0.30 and $3.07 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming SeaStar Medical Holding Corporation. SeaStar Medical Holding Corporation is a $8.6M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming SeaStar Medical Holding Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for SeaStar Medical Holding Corporation. Coverage tracks SeaStar Medical Holding Corporation within Biotechnology (Healthcare). Press releases and market coverage, newest first.